Evolving Therapeutic Paradigms in Bladder Cancer: the Impact of Immunotherapy and Antibody-Drug Conjugates
Shahd Mustafa Ibrahim, Ahmed Attia Ahmed Abdelmoaty, Ahmed Helmy Abdelhaseb
						Bladder cancer is a significant global health challenge. Despite advances in surgery and platinum-based chemotherapy over the decades, limited improvements in clinical outcomes have been observed. However, recent years have witnessed the development of immune checkpoint inhibitors (ICIs) and antibody-drug conjugates (ADCs) that has transformed the therapeutic landscape of bladder cancer across dif...   
                    REVIEW | Published: 24 Oct 2025
Annals of Urologic Oncology, Articles, Online First

 Submit Manuscript
Submit Manuscript